Pulmicort Asthma Prevention (Post-PAC)
This prospective study will evaluate the feasibility of the defined decision tree for the treatment of asthmatic young children. Children who develop episode (=3 consecutive days) of any troublesome lower respiratory symptoms are treated according to a strictly pre-defined multi-steps treatment algorithm until the age of 6 years.
|Study Design:||Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||A Study to Evaluate the Feasibility of a Treatment Algorithm in Newly Diagnosed Asthmatic Children. An Open Follow-up to Asthma Prevention in Infants/Young Children (PAC)|
- Success rate of the treatment algorithm: Frequency of protocol deviations, asthma exacerbations, different treatment steps.
- Efficacy - development of lung function.
- Acceptability of the treatment algorithm by the parents.
- Growth rate and BMD.
- Exhaled nitrogen Oxide, bronchohyperresponsiveness.
|Study Start Date:||July 2001|
|Study Completion Date:||June 2006|
|Primary Completion Date:||May 2006 (Final data collection date for primary outcome measure)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00233584
|Study Director:||AstraZeneca Denmark Medical Director, MD||AstraZeneca|